Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
This bill would repeal a specific provision in a 1998 law that governs the Office of National Drug Control Policy (the federal agency responsible for coordinating the nation's drug control strategy). The provision being repealed, known as section 704(b)(12), restricts the types of drug policy research and information the government can fund or support. By removing this restriction, the bill would allow the federal government to fund and promote drug policies based more broadly on scientific evidence rather than being limited by the current regulatory constraints. The legislation affects federal drug policy agencies and researchers who study drug-related issues. No specific funding amounts or implementation timelines are outlined in the bill text provided.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.